Literature DB >> 11198187

GASTON: an architecture for the acquisition and execution of clinical guideline-application tasks.

P A De Clercq1, J A Blom, A Hasman, H H Korsten.   

Abstract

Recently, studies have shown the benefits of using clinical guidelines in the practice of medicine. There have been numerous efforts to develop clinical decision support systems that support guideline-based care in an automated fashion, covering a wide range of clinical settings and tasks. Despite these efforts, only a few systems progressed beyond the prototype stage and the research laboratory. For guideline-based clinical decision support systems to be successful, a balance must be made between intuitive but imprecise representations usually encountered by most of today's systems and representations that support a strong underlying clinical performance model. The project described in this paper tries to achieve such a balance. It presents the GASTON architecture that contains a set of reusable software components for the application of guidelines, including design-time components to facilitate the guideline authoring process based on guideline representation models along with execution-time components for building decision support systems that incorporate these guidelines. This architecture was used to develop several guideline representation models such as a rule-based representation to model rule-based guidelines and guideline representation models that address more complex tasks. Also, decision support systems that incorporate these models were developed with the architecture. For the representation and application of various classes of guidelines, rules were also viewed as instances of more complex tasks. By identifying similar characteristics of sets of rules, we developed several tasks such as a drug intera ction and drug contraindication task. Based on these models, we have developed and validated guidelines and decision support systems for use in several application domains such as intensive care, family physicians and psychiatry. In order to be able to represent more complex time-oriented plans, new guideline representation models are being developed.

Mesh:

Year:  2000        PMID: 11198187     DOI: 10.1080/146392300455558

Source DB:  PubMed          Journal:  Med Inform Internet Med        ISSN: 1463-9238


  6 in total

1.  Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability.

Authors:  Richard N Shiffman; George Michel; Richard M Rosenfeld; Caryn Davidson
Journal:  J Am Med Inform Assoc       Date:  2011-08-16       Impact factor: 4.497

2.  [Guidelines based on decision support software. Quality management in neurological outpatient schizophrenia treatment].

Authors:  B Janssen; R Menke; F Pourhassan; D Gessner-Ozokyay; R Peters; W Gaebel
Journal:  Nervenarzt       Date:  2006-05       Impact factor: 1.214

3.  A Design Methodology for Medical Processes.

Authors:  Simona Ferrante; Stefano Bonacina; Giuseppe Pozzi; Francesco Pinciroli; Sara Marceglia
Journal:  Appl Clin Inform       Date:  2016-03-30       Impact factor: 2.342

Review 4.  Clinical decision support systems in child and adolescent psychiatry: a systematic review.

Authors:  Roman Koposov; Sturla Fossum; Thomas Frodl; Øystein Nytrø; Bennett Leventhal; Andre Sourander; Silvana Quaglini; Massimo Molteni; María de la Iglesia Vayá; Hans-Ulrich Prokosch; Nicola Barbarini; Michael Peter Milham; Francisco Xavier Castellanos; Norbert Skokauskas
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-04-28       Impact factor: 4.785

5.  System for Context-Specific Visualization of Clinical Practice Guidelines (GuLiNav): Concept and Software Implementation.

Authors:  Jonas Fortmann; Marlene Lutz; Cord Spreckelsen
Journal:  JMIR Form Res       Date:  2022-06-22

6.  Coupling computer-interpretable guidelines with a drug-database through a web-based system--The PRESGUID project.

Authors:  Jean-Charles Dufour; Dominique Fieschi; Marius Fieschi
Journal:  BMC Med Inform Decis Mak       Date:  2004-03-02       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.